#EASD2022 Interview with Rury Holman and Amanda Adler on the UKPDS 44 Year Follow-up @EASDiabetes

Uploaded September 2022 | Updated September 2026, 3 days ago

Discover the impact of the UKPDS (UK Prospective Diabetes Study), which has shaped diabetes care for over 40 years. In this session from the EASD 2022 Annual Meeting, Dr Rury Holman and Dr Amanda Adler share remarkable insights into the legacy effect of early glycemic control. The study’s findings continue to transform the way we treat diabetes, emphasizing the importance of early intervention and long-term control. Learn about the lasting benefits, the economic impact, and the new data on dementia risk linked to good glycemic control.

#easd2022 #UKPDS #diabetes

#EASD2022 Interview with Rury Holman and Amanda Adler on the UKPDS 44 Year Follow-up

Best of EASD 2025 by the EASD Early Career Academy - featuring Dr. Lorenzo Nesti

EASD 2025: What if Insulin Resistance Could be Treated like Hypertension or High Cholesterol?

EASD 2023 - EASD/ADA consensus report on hyperglycaemic crises in adult patients with diabetes

EASD 2023 - Peter Thorn and Sushil Rane explaining the relationship between diabetes and the brain

EASD 2025: Results from the SOUL Trial - The Cardiologists Perspective

Meet the EASD Early Career Academy - Introducing Pierre Larraufie

#EASD2022 Interview with the EASD-Lilly Centennial Anniversary Prize Lecturerer Matthias Tschöp

9th ECA Webinar: How to DiRECT understanding of t2d into a major advance in clinical care

EASD 2023 - What is the Hypo-RESOLVE project?

EASD 2024 Exlusive Interview with Dr. Rodica Busui - Camillo Golgi Award Winner

EASD 2024 - The Future of Type 1 Diabetes - Will We See Prevention or Cure?